Skip to main content

Yigul Nautomovic

Analyst

Citigroup

Equibles does not estimate personal net worth.

About Yigul Nautomovic

Yigul Nautomovic is recorded as Analyst at Citigroup. Yigul Nautomovic has spoken on 1 investor event across 1 company, most recently for Arcturus Therapeutics Holdings Inc. on September 23, 2026. The companies whose calls Yigul Nautomovic spoke on are classified in the Healthcare sector.

Yigul Nautomovic on recent calls

“Could you speak a little bit more about the new formulation? Because you're moving from 250 mil, you know, at 0.5 mg per kg to 40 ml at 0.3 mg per kg, which seems, just by rough calculation, you know, a step up of about maybe 3x in concentration, you know, for the average individual.”
Analyst — Citigroup, Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform | Presentation ·

Affiliation history

  • Citigroup

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity